1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ACLARIS THERAPEUTICS INC
Aclaris Therapeutics Inc XNAS: ACRS
1.59 0.02 (1.27%)
586.3K
XNAS Volume

XNAS 14 Jul, 2025 1:16 PM (EDT)

Aclaris Therapeutics Inc - ACRS - stock price prediction, stock price target, analyst ratings from 8 analysts

Aclaris Therapeutics Inc has a share price target of US$ 8, revenue growth forecast of -68.7%, and profit growth estimate of 49.2% for FY25, based on top 8 analyst calls.